How do we address neglected sulfur pharmacophores in drug discovery?

Expert Opin Drug Discov. 2021 Nov;16(11):1227-1231. doi: 10.1080/17460441.2021.1948008. Epub 2021 Jul 2.

Authors

Michael J Tilby¹, Michael C Willis¹

Affiliation

¹ Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK.

PMID: 34212815
DOI: 10.1080/17460441.2021.1948008

No abstract available

Publication types

Editorial

MeSH terms

Drug Discovery*
Humans
Molecular Structure
Neglected Diseases
Sulfur*

Substances

Sulfur